NDRG1 and inflammatory breast carcinoma: We are the first to show that NDRG1 expression was an independent prognostic factor for worse survival outcomes in patients with IBC, and together with other important prognostic factors, such as ER status and disease stage, can be used to further stratify prognostic outcome or treatment response in refractory tumors.